, Singapore
112 views

CapitaLand and Ascendas Reit to jointly redevelop 1 Science Park Drive

The redevelopment will cost $883m.

CapitaLand Development (CLD) and Ascendas Reit have formed a joint venture to invest $883m in redeveloping 1 Science Park Drive into a life science and innovation campus.

It follows the sale of 1 Science Park Drive by Ascendas Reit to the joint venture for $103m. CLD owns a 66% interest in the joint venture, while Ascendas Reit owns the remaining 34%.

Expected to be fully completed by 2025, 1 Science Park Drive caters to demand from tenants in new economy sectors such as biomedical sciences, digital and technology, which are continuing to expand in Singapore amidst a greater focus on healthcare, deep tech and accelerating digital transformation. About 80,000sqm or 71% of the 112,500sqm of business park space has been designed to accommodate biomedical research and development (R&D) activities.

CLD CEO Jason Leow said, "As the master developer, owner and operator of SSP 1, we have been steadily unlocking the precinct's potential through redevelopment and land intensification initiatives and will continue to do so in the next few years. The redevelopment of 1 Science Park Drive is the latest milestone in this strategy, aimed at providing modern workspace solutions in a campus-style environment that will reinforce SSP 1's position as one of the most prestigious R&D hubs in the region."

"On a stabilised basis, the investment is expected to generate a net property income yield of approximately 6.3%, re-creating value for Ascendas Reit's Unitholders. We will also have the first right to acquire the remaining 66% interest when the redeveloped property achieves stabilised occupancy," added Ascendas Reit CEO William Tay.

Since its development in the 1980s, SSP 1 has become the leading hub for R&D in Southeast Asia. Today, it is home to over 350 laboratories, multinational corporations, and leading global digital and technology companies. SSP 1 is about a 15-minute drive from Singapore's Central Business District. Its proximity to the National University of Singapore and National University Hospital has made it an ideal location for R&D, innovation and test-bedding.

Join Singapore Business Review community

Follow the link s for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Exclusives

Singapore opens door to foreign stablecoins under tighter rules
Banks may need separate companies to issue stablecoins under the proposed framework.
Singapore's most notable architecture professionals under 40 of 2026
The honourees span five firms, with women in the majority and a combined portfolio that includes a $960m hospital campus.